Reference transaction
Advisor to EMPERRA GmbH
on the acquisition of the ESYSTA technology
Saxenhammer advised Emperra GmbH E-Health Technologies in the process of acquiring the ESYSTA® technology, including its associated IP portfolio.
The Potsdam-based digital health company is a pioneer in developing innovative solutions for diabetes mellitus, aiming to sustainably improve patient care. Emperra will continue to advance the ESYSTA® technology and pursue a growth strategy both in Germany and internationally.
Emperra GmbH E-Health Technologies is a medical technology company based in Potsdam that develops digital solutions for diabetes management. With its ESYSTA system, Emperra offers a connected, digital diabetes diary that automatically records blood glucose and insulin data and securely transmits them to both doctors and patients. This enables more efficient therapy, improves the quality of care, and reduces administrative effort in everyday diabetes management.
